2891 - 2900 of 6570 Results
Title
Year
-
OPENTitle: Distribution of phosphorylated alpha-synuclein in non-diseased brain implicates olfactory bulb mitral cells in synucleinopathy pathogenesisJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page: 43End Page: 43Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00491-3Best OA location URL: https://www.nature.com/articles/s41531-023-00491-3.pdfCitation Count: 37
- EEG Entropy in REM Sleep as a Physiologic Biomarker in Early Clinical Stages of Alzheimer’s Disease2023OPENTitle: EEG Entropy in REM Sleep as a Physiologic Biomarker in Early Clinical Stages of Alzheimer’s DiseaseJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 91Issue #: 4Start Page: 1557End Page: 1572Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-221152Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10039707/pdf/nihms-1865876.pdfCitation Count: 31
-
OPENTitle: Australian Parkinson’s Genetics Study (APGS): pilot (n=1532)Journal Name: BMJ OpenPublisher: BMJVol: 12Issue #: 2Start Page: e052032End Page: e052032Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/bmjopen-2021-052032Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/12/2/e052032.full.pdfCitation Count: 13
-
OPENTitle: Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 8Start Page: e859End Page: e871Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000013218Best OA location URL: https://n.neurology.org/content/neurology/98/8/e859.full.pdfCitation Count: 197
-
OPENTitle: Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease: Real-World Evidence From G7 CountriesJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 303End Page: 318Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00313-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00313-9.pdfCitation Count: 11
-
OPENTitle: Real-World Adherence to Tetrabenazine or Deutetrabenazine Among Patients With Huntington’s Disease: A Retrospective Database AnalysisJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 435End Page: 448Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00309-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00309-5.pdfCitation Count: 16
-
OPENTitle: Nanobodies as allosteric modulators of Parkinson’s disease–associated LRRK2Journal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 119Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2112712119Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8892280Citation Count: 58
-
OPENTitle: True ultra-low-dose amyloid PET/MRI enhanced with deep learning for clinical interpretationJournal Name: European Journal of Nuclear Medicine and Molecular ImagingPublisher: Springer Science and Business Media LLCVol: 48Issue #: 8Start Page: 2416End Page: 2425Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00259-020-05151-9Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8891344Citation Count: 57
-
OPENTitle: Subcellular proteomics of dopamine neurons in the mouse brainJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.70921Best OA location URL: https://doi.org/10.7554/elife.70921Citation Count: 65
-
OPENTitle: Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label TreatmentJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 459End Page: 469Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00317-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00317-5.pdfCitation Count: 7